BridgeMD
New treatment option for Type 1 Diabetes Mellitus
Official title Gamification Intervertion in Children With Type 1 Diabetes
ClinicalTrials.gov ID: NCT07409701
What this study is testing
- What it's testing
- Objective: This study aims to examine the effect of education provided through gamification methods on health literacy and quality of life in children diagnosed with type 1 diabetes (T1DM). Materials and Methods: The study is planned as a randomized controlled trial with a pre-test-post-test, parallel design (1:1).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 12
You may be able to join if
- Diagnosed with type 1 diabetes
- Aged between 8 and 12 years
- Diagnosed with type 1 diabetes for at least 1 year and having received standard diabetes education
- Able to read and write
You likely can't join if
- Presence of speech, hearing, or visual impairments
- Presence of any other comorbid chronic disease
- Presence of cognitive impairment
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Yenimahalle, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Yenimahalle, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.